Effect of various forms of the C1 esterase inhibitor (C1-INH) and DAF on complement mediated xenogeneic cell lysis

被引:20
作者
Fukuta, D
Miyagawa, S
Yamada, M
Matsunami, K
Kurihara, T
Shirasu, A
Hattori, H
Shirakura, R
机构
[1] Osaka Univ, Grad Sch Med, Div Organ Transplantat, Dept Regenerat Med, Suita, Osaka 5650871, Japan
[2] Anim Engn Res Inst, Ibaraki, Japan
[3] Nipro Corp, Res & Dev Lab, Osaka, Japan
关键词
C1-INH; complement; xenograft;
D O I
10.1034/j.1399-3089.2003.01120.x
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The purpose of the present study was to assess the effect of various forms of the surface-bound form of the C1 esterase inhibitor (C1-INH-PI) and decay accelerating factor (DAF) on xenogenic cells. cDNAs of various deletion mutants of the C1-INH-PI, such as delta-1-99 amino acid (AA), delta-108-183AA loop, delta-whole loop, delta-exon5, delta-exon6 + 7, and delta-exon5 + 6 + 7, and that of DAF, the delta-short consensus repeat (SCR) 1-DAF were established. While all deletion mutants of C1-INH-PI except the delta-1-99AA were expressed in the cytoplasm but not on the cell surface, the delta-1-99AA was clearly expressed on the xenogeneic cell surface. Amelioration of complement-mediated xenogeneic cell lysis by delta-1-99AA was next tested, and compared with delta-SCR1 DAF. Both molecules blocked human complement-mediated cell lysis by approximately 57 to 90 and 93 to 98%, respectively, in Chinese hamster ovarian tumor (CHO) cells and pig endothelial cells (PECs). The CHO cell transfectants were incubated with 20% normal human serum, and the amounts of C4 and C3 deposition on the cell surface were analysed by flow cytometry. The DAF transfectant showed a large amount of C4-deposition and much less C3-deposition than the controls (approximately 85% suppression), whereas the delta-1-99AA showed approximately a 40% suppression in both C4- and C3-deposition. Consequently, both the delta-1-99AA C1-INH-PI and delta-SCR1 DAF molecules are quite effective in down-regulating the xenogeneic cell lysis, but accomplished this in different manners.
引用
收藏
页码:132 / 141
页数:10
相关论文
共 46 条
[21]   THE MECHANISM OF DISCORDANT XENOGRAFT REJECTION [J].
MIYAGAWA, S ;
HIROSE, H ;
SHIRAKURA, R ;
NAKA, Y ;
NAKATA, S ;
KAWASHIMA, Y ;
SEYA, T ;
MATSUMOTO, M ;
UENAKA, A ;
KITAMURA, H .
TRANSPLANTATION, 1988, 46 (06) :825-830
[22]   Remodeling of the major pig xenoantigen by N-acetylglucosaminyltransferase III in transgenic pig [J].
Miyagawa, S ;
Murakami, H ;
Takahagi, Y ;
Nakai, R ;
Yamada, M ;
Murase, A ;
Koyota, S ;
Koma, M ;
Matsunami, K ;
Fukuta, D ;
Fujimura, T ;
Shigehisa, T ;
Okabe, M ;
Nagashima, H ;
Shirakura, R ;
Taniguchi, N .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (42) :39310-39319
[23]   Regulation of natural killer cell-mediated swine endothelial cell lysis through genetic remodeling of a glycoantigen [J].
Miyagawa, S ;
Nakai, R ;
Yamada, M ;
Tanemura, M ;
Ikeda, Y ;
Taniguchi, N ;
Shirakura, R .
JOURNAL OF BIOCHEMISTRY, 1999, 126 (06) :1067-1073
[24]  
MORAN P, 1992, J IMMUNOL, V149, P1736
[25]   Production of transgenic pigs expressing human DAF (CD55) regulated by the porcine MCP gene promoter [J].
Murakami, H ;
Nagashima, H ;
Takahagi, Y ;
Fujimura, T ;
Miyagawa, S ;
Okabe, M ;
Seya, T ;
Shigehisa, T ;
Taniguchi, N ;
Shirakura, R ;
Kinoshita, T .
TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) :2505-2506
[26]  
NICHOLSONWELLER A, 1982, J IMMUNOL, V129, P184
[27]  
NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D
[28]   SHORT CONSENSUS REPEAT-3 DOMAIN OF RECOMBINANT DECAY-ACCELERATING FACTOR IS RECOGNIZED BY ESCHERICHIA-COLI RECOMBINANT DR ADHESIN IN A MODEL OF A CELL-CELL INTERACTION [J].
NOWICKI, B ;
HART, A ;
COYNE, KE ;
LUBLIN, DM ;
NOWICKI, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2115-2121
[29]  
OSTREICHER BH, 1996, TRANSPLANTATION, V62, P1693
[30]  
Platt JL, 1998, NATURE, V392, P11